Tags: Mitochondria & Metabolic Function

announcements

Funding Supports New Approaches to Treat Multiple Types of Dementia

The ADDF announces two investments in programs targeting mitochondria and the progranulin gene.

announcements

$4 Million in New Grants Support Several First-in-Class Dementia Treatments

We recently awarded eight new grants totaling over $4 million to advance treatments for Alzheimer’s and related dementias. Several of the awards support new approaches to treating these diseases.

announcements

Three New Grants Support Promising Treatments for Alzheimer's Disease

The ADDF awarded three new grants in July and August for potential new treatments for Alzheimer's and other dementias. 

announcements

ADDF and FMM Partner to Support Novel Research for Mitochondrial-Directed Therapies

The ADDF and the Foundation for Mitochondrial Medicine awarded $200,000 to James Bennett, M.D., Ph.D. to further research gene therapy of mitochondrial protein in mice with experimental Alzheimer's disease.